Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics.
Lorente-Sorolla C, Bernaola J, Sánchez-Mellado D, Gil-Martínez M, Naharro-González S, Betancor D, Fernández-Nieto M, Pinillos-Robles EJ, Santillán Coello JM, Villacampa-Aubá JM, Rodríguez-Nieto MJ, Sastre J, Valverde-Monge M, Rodrigo-Muñoz JM, Del Pozo V.
Lorente-Sorolla C, et al. Among authors: villacampa auba jm.
Allergy. 2023 Nov;78(11):3027-3031. doi: 10.1111/all.15872. Epub 2023 Aug 29.
Allergy. 2023.
PMID: 37643083
No abstract available.